EMEA-002569-PIP04-19

Key facts

Active substance
rosuvastatin / ramipril
Therapeutic area
Cardiovascular diseases
Decision number
P/0343/2019
PIP number
EMEA-002569-PIP04-19
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
  • Prevention of cardiovascular events
  • Treatment of hypertension
  • Treatment of lipid metabolism disorders
Route(s) of administration
Oral use
Contact for public enquiries
EGIS Pharmaceuticals PLC 

Tel. +36 18032414
E-mail: registry@registry.hu

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating